Project Grant R01MH136958
- The National Institute of Mental Health awarded the University of North Carolina at Chapel Hill $1,369,530 on September 23, 2025, under the Mental Health Research Grants program (CFDA 93.242) to evaluate field-based delivery of long-acting injectable antiretroviral therapy for persons with HIV who are out of care in North Carolina. The study, titled "RELAI" (Reaching Persons with HIV Who Are Out of Care Through Expedited Access to Long-Acting Injectable Antiretroviral Therapy),...
- The National Institute of Mental Health awarded the University of North Carolina at Chapel Hill $1,177,156 on March 17, 2026, under the Mental Health Research Grants program (CFDA 93.242) to integrate inpatient hospital records and statewide HIV surveillance data to characterize post-discharge care engagement among people with HIV in North Carolina. The project, titled "Leveraging Inpatient Records to Characterize the HIV Care Continuum in North Carolina" (LINC-NC), addresses the gap...
- The National Institute of Mental Health awarded the University of North Carolina at Chapel Hill $793,185 on April 7, 2026, under the Mental Health Research Grants program (CFDA 93.242) to investigate inactivation of the ISR/ATF4 signaling pathway as a mechanism to stabilize and reduce HIV reservoirs in latently infected cells. The award funds research into how the integrated stress response and ATF4 transcription factor regulate HIV transcription and latency. The project will characterize how...
- The National Institute of Mental Health awarded the University of North Carolina at Chapel Hill $2.689 million under the Mental Health Research Grants program (CFDA 93.242) on August 1, 2026, for the Psychiatric Genomics Consortium: Mechanisms and Translation (R01MH142618). The award funds integrated genetic and functional genomic analysis of psychiatric disorders across three coordinated aims: identifying genetic variants associated with serious psychiatric disorders through rigorous...
- The National Institute of Mental Health awarded Duke University $508,072 on May 18, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a hybrid type-2 effectiveness-implementation trial testing the integration of Sauti Ya Vijana (SYV, the Voice of Youth), a peer-led, group-based mental health treatment, within HIV clinical care for youth living with HIV in Tanzania and the United States. The award funds research designed to address the mental health treatment gap...
- The National Institute of Mental Health awarded the University of North Carolina at Chapel Hill $124,128 on December 15, 2025, under the Mental Health Research Grants program (CFDA 93.242) to characterize trajectories of structure-function coupling in human brain networks from birth through adolescence and examine relationships to transdiagnostic psychopathology. The project leverages the UNC Early Brain Development Study, a longitudinal dataset with ten timepoints of diffusion and resting-state...
- The National Institute of Mental Health awarded The Rand Corporation $676,820 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to evaluate the decentralization and scale-up of integrated chronic care clinics in Malawi. The award funds a stepped-wedge cluster randomized trial that would permanently transition Malawi's HIV delivery platform—a network of 700 clinics serving over 900,000 clients—into full-time integrated chronic care facilities providing daily...
- The National Institute of Mental Health awarded the University of Washington $699,750 on May 7, 2026, under the Mental Health Research Grants program (CFDA 93.242) to adapt and evaluate the "Do More, Feel Better" behavioral activation intervention for older people living with HIV who experience depression and have limited access to professional mental health care. The project addresses a documented gap: older people living with HIV (age 50 and above) represent more than half of the...
- The National Institute of Mental Health awarded the University of Alabama at Birmingham $678,550 on July 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a randomized clinical trial evaluating the Advanced HIV Re-engagement in Care (ARC) intervention in Zambia. ARC is a package of evidence-based, theory-informed elements delivered by supervised community health workers during hospitalization and the post-discharge period to improve outcomes for people with...
- The National Institute of Mental Health awarded $1,488,310 to the University of North Carolina at Chapel Hill on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to evaluate personalized aperiodic transcranial alternating current stimulation as a treatment for antenatal depression. The research project, titled "Personalized Aperiodic Transcranial Alternating Current Stimulation as a Treatment for Antenatal Depression" (R61MH144538), develops and tests...
The National Institute of Mental Health awarded the University of North Carolina at Chapel Hill $1,454,676 on August 7, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a randomized controlled trial of problem-solving therapy (PST) to improve common mental disorder and HIV care outcomes for people with HIV on antiretroviral therapy in Vietnam. The study tests a task-shifted, non-specialist-delivered mental health intervention designed to address the gap between the high prevalence of untreated common mental disorders among people with HIV and the severe shortage of mental health workforce capacity in low- and middle-income countries. The research deliberately situates the trial in Vietnam to create a high-contrast environment where intervention mechanisms and causal pathways linking mental health improvements to HIV outcomes are most observable, with findings intended to inform implementation in resource-constrained U.S. settings including rural and safety-net clinics. Work is performed at the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. The period of performance runs through July 31, 2031. UNC-Chapel Hill, operating through its Office of Sponsored Research, is the recipient institution.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $45.4k | 8/20/26 | ||
| Not listed | $704.6k | 8/10/26 |